512 related articles for article (PubMed ID: 8602631)
1. Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII.
Rick ME; Krizek DM
Am J Hematol; 1996 Apr; 51(4):302-6. PubMed ID: 8602631
[TBL] [Abstract][Full Text] [Related]
2. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
Jacquemin M
Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
[TBL] [Abstract][Full Text] [Related]
3. Variant von Willebrand disease with defective binding to factor VIII: the first case from Japan.
Nishino M; Miura S; Yoshioka A; Kuwahara I; Nishimura T; Hamada K; Fukui H
Int J Hematol; 1993 Apr; 57(2):163-73. PubMed ID: 8494994
[TBL] [Abstract][Full Text] [Related]
4. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
[TBL] [Abstract][Full Text] [Related]
5. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of the Arg91Gln substitution in the factor VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression.
Lavergne JM; Piao Y; Ribba AS; Girma JP; Siguret V; Piétu G; Boyer-Neumann C; Schandelong A; Bahnak BR; Meyer D
Thromb Haemost; 1993 Oct; 70(4):691-6. PubMed ID: 8115998
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F.
Castaman G; Eikenboom JC; Contri A; Rodeghiero F
Thromb Haemost; 2000 Aug; 84(2):351-2. PubMed ID: 10959713
[No Abstract] [Full Text] [Related]
8. A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations.
Nesbitt IM; Hampton KK; Preston FE; Peake IR; Goodeve AC
Thromb Haemost; 1999 Sep; 82(3):1061-4. PubMed ID: 10494764
[TBL] [Abstract][Full Text] [Related]
9. [Importance of the study of the binding of factor VIII to von Willebrand factor in hemophilia A].
Batlle J; Blanco-López MJ; Castiñeira MP; López-Fernández MF
Sangre (Barc); 1992 Jun; 37(3):211-24. PubMed ID: 1359656
[No Abstract] [Full Text] [Related]
10. Two new candidate mutations in type IIA von Willebrand's disease (Arg834-->Gly, Gly846-->Arg) and one polymorphism (Tyr821-->Cys) in the A2 region of the von Willebrand factor.
Donnér M; Kristoffersson AC; Berntorp E; Scheibel E; Thorsen S; Dahlbäck B; Nilsson IM; Holmberg L
Eur J Haematol; 1993 Jul; 51(1):38-44. PubMed ID: 8348943
[TBL] [Abstract][Full Text] [Related]
11. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of von Willebrand disease.
Mazurier C; Ribba AS; Gaucher C; Meyer D
Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
[TBL] [Abstract][Full Text] [Related]
13. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
Eikenboom JC; Castaman G; Kamphuisen PW; Rosendaal FR; Bertina RM
Thromb Haemost; 2002 Feb; 87(2):252-7. PubMed ID: 11859851
[TBL] [Abstract][Full Text] [Related]
14. Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.
Casonato A; Pontara E; Boscaro M; Dannhauser D; Sartori MT; Girolami A
Haematologia (Budap); 1993; 25(1):57-67. PubMed ID: 8339998
[TBL] [Abstract][Full Text] [Related]
15. [Variant type von Willebrand disease with defective binding to factor VIII].
Shima M
Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):430-3. PubMed ID: 9833534
[No Abstract] [Full Text] [Related]
16. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
17. Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.
Mazurier C; Meyer D
Thromb Haemost; 1996 Aug; 76(2):270-4. PubMed ID: 8865544
[No Abstract] [Full Text] [Related]
18. [Mutation (Ala737-->Glu) in type 2A von Willebrand disease].
Wang Y; Zhang J; Wan H
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):117-9. PubMed ID: 11601234
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of von Willebrand disease and its clinical implications.
Haematologica; 2004 Sep; 89(9):1036. PubMed ID: 15377463
[No Abstract] [Full Text] [Related]
20. Type 2N von Willebrand disease: rapid genetic diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F)--detection of a novel candidate type 2N mutation: C2810T (R854W).
Bowen DJ; Standen GR; Mazurier C; Gaucher C; Cumming A; Keeney S; Bidwell J
Thromb Haemost; 1998 Jul; 80(1):32-6. PubMed ID: 9684781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
